The global AAV contract development and manufacturing organizations market size is expected to reach USD 4.7 billion by 2035 and it is expected to expand at 17.1% CAGR from 2023 to 2035. The main drivers of this market are the robust pipeline of adeno-associated virus (AAV) for gene therapies & vaccines, technological advancements in manufacturing of adeno-associated viral vectors, and a highly competitive market with various strategies undertaken by key market players. For instance, in September 2022, Rocket Pharmaceuticals, Inc. acquired Renovacor, Inc., a biotechnology company, focused on offering precision medicines. This acquisition is in line with the company's aim to strengthen its position as a pioneer in adeno-associated virus (AAV)-based gene therapy for cardiac illness.
AAV-mediated gene therapy products that address fatal and severely disabling diseases have proliferated in recent years, with investment in academic startups, and several products entering clinical trials by major pharmaceutical companies. AAV vector has become a highly effective treatment for cardiovascular, neurological, and immunological illnesses as well as cancer. Due to these factors, market participants and CDMOs implement strategies like M&A, expansions, product launches, collaborations, and partnerships.
Significant advancements have been made in the use of viral vectors within the gene therapy & gene-modified cell therapy fields over the past 10 years. Vendors have innovated existing technologies as part of the industry's ongoing improvement efforts to support the special needs of viral vector manufacturing. These developments include the introduction of iCELLis technology for adherent cell culture and the creation of chromatographic resins for the production of viral vectors. Furthermore, next-generation analytics such as Droplet Digital Polymerase Chain Reaction (ddPCR), Analytical Ultracentrifugation (AUC), Size-Exclusion Chromatography-Multi-Angle Light Scattering (SEC-MALS), and Capillary Electrophoresis-Sodium Dodecyl Sulphate (CE-SDS) facilitate accurate & precise quantification.
AAV-mediated gene therapy products that address fatal and severely disabling diseases have proliferated in recent years, with investment in academic startups, and several products entering clinical trials by major pharmaceutical companies. AAV vector has become a highly effective treatment for cardiovascular, neurological, and immunological illnesses as well as cancer. Due to these factors, market participants and CDMOs implement strategies like M&A, expansions, product launches, collaborations, and partnerships.
Significant advancements have been made in the use of viral vectors within the gene therapy & gene-modified cell therapy fields over the past 10 years. Vendors have innovated existing technologies as part of the industry's ongoing improvement efforts to support the special needs of viral vector manufacturing. These developments include the introduction of iCELLis technology for adherent cell culture and the creation of chromatographic resins for the production of viral vectors. Furthermore, next-generation analytics such as Droplet Digital Polymerase Chain Reaction (ddPCR), Analytical Ultracentrifugation (AUC), Size-Exclusion Chromatography-Multi-Angle Light Scattering (SEC-MALS), and Capillary Electrophoresis-Sodium Dodecyl Sulphate (CE-SDS) facilitate accurate & precise quantification.
AAV Contract Development And Manufacturing Organizations Market Report Highlights
- The downstream processing segment dominated the market with a revenue share of 54.8% in 2022. The main driver of this market is the small size of AAV capsids and they are very stable as compared to other viruses, so purification of AAV vectors is relatively easy
- Based on culture type, the adherent culture segment accounted for the largest revenue share of 58.9% in 2022. As they require less specialized bioengineering knowledge than three-dimensional platforms
- Based on end user, pharmaceutical and biopharmaceutical companies dominated the market with a revenue share of 53.5% in 2022and is also anticipated to show the highest growth over the forecast period
- Asia Pacific is projected to witness the fastest CAGR of 19.7% during the forecast years. The large patient base, lower overall costs, skilled workforce, and changes in the regulatory scenario are the key factors driving the market growth
Table of Contents
Chapter 1 Report Scope1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
Chapter 2 Research Methodology
2.1 Research Methodology
2.1.1 Information Procurement
2.2 Information Or Data Analysis
2.3 Market Formulation & Validation
2.4 Region-Wise Market Calculation
2.4.1 Approaches Used To Estimate The Market Size
2.4.1.1 Approach 1: Region-Wise Market Estimation Using Bottom-Up Approach
2.4.1.2 Approach 2: Parent Market Analysis
2.4.1.3 Approach 3: Commodity Flow (Company Share Analysis)
2.4.2 Global Market: CAGR Calculation
2.4.3 Global AAV Cdmo Market Calculation, Methodology, And Assumptions
2.5 Model Details
2.5.1 Commodity Flow Analysis
2.6 List Of Secondary Sources
2.7 Primary Research:
2.7.1 Primary Sources
2.7.1.1 Data For Primary Interviews In North America
2.7.1.2 Data For Primary Interviews In Europe
2.7.1.3 Data For Primary Interviews In Asia Pacific
2.7.1.4 Data For Primary Interviews In Latin America
2.7.1.5 Data For Primary Interviews In Mea
2.8 List Of Abbreviations
2.9 Objectives
2.9.1 Objective - 1:
2.9.2 Objective - 2:
2.9.3 Objective - 3:
2.9.4 Objective - 4:
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Segment Snapshot
3.3 Competitive Landscape Snapshot
Chapter 4 Pharmaceutical Dissolution Testing Services Market Variables, Trends, and Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Ancillary Market Outlook
4.2 Market Driver Analysis
4.2.1. Robust pipeline of adeno-associated virus for gene therapies and vaccines
4.2.2 Technological advancements in manufacturing adeno - associated viral vectors
4.2.3 Highly competitive Market & various strategies undertaken by Market entities
4.2.3.1 Acquisitions
4.2.3.2 Collaboration
4.2.3.3 Expansion
4.2.3.4 Partnership
4.3 Market Restraint Analysis
4.3.1 Regulatory, scientific, and ethical challenges associated with gene therapy & viral vectors
4.3.2 Manufacturing challenges in producing AAV viral vectors
4.4 AAV Cdmo Market: Analysis Tools
4.4.1 Porter’s Five Forces Analysis
4.4.2 PEST Analysis
4.5 Impact Of COVID-19 On AAV Cdmo Market
4.5.1 COVID - 19 Impact
4.5.2 COVID - 19 Reformation Strategies
Chapter 5 Global Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market
5.1 Definitions & Scope
5.2 Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations: Market Share Analysis, 2022 & 2035
5.3 Upstream Processing
5.3.1 Upstream Processing Market, 2018 - 2035 (USD Million)
5.3.2 Vector Amplification & Expansion
5.3.2.1 Vector Amplification & Expansion Market, 2018 - 2035 (USD Million)
5.3.3 Vector Recovery & Harvesting
5.3.3.1 Vector Recovery & Harvesting Market, 2018 - 2035 (USD Million)
5.4 Downstream Processing
5.4.1 Downstream Processing Market, 2018 - 2035 (USD Million)
5.4.2 Purification
5.4.2.1 Purification Market, 2018 - 2035 (USD Million)
5.4.3 Fill Finish
5.4.3.1 Fill Finish Market, 2018 - 2035 (USD Million)
Chapter 6 Global Adeno - Associated Virus Contract Development & Manufacturing Market: Culture Type Segment Analysis
6.1 Definitions & Scope
6.2 Adeno - Associated Virus Contract Development & Manufacturing Organizations: Market Share Analysis, 2022 & 2035
6.3 Adherent Culture
6.3.1 Adherent Culture Market, 2018 - 2035 (USD Million)
6.4 Suspension Culture
6.4.1 Suspension Culture Market, 2018 - 2035 (USD Million)
Chapter 7 Global Adeno - Associated Virus Contract Development & Manufacturing Organizations Market: Application Segment Analysis
7.1 Definitions & Scope
7.2 Adeno - Associated Virus Contract Development & Manufacturing Organizations: Market Share Analysis, 2022 & 2035
7.3 Cell & Gene Therapy Development
7.3.1 Cell & Gene Therapy Development Market, 2018 - 2035 (USD Million)
7.4 Vaccine Development
7.4.1 Vaccine Development Market, 2018 - 2035 (USD Million)
7.5 Biopharmaceutical and Pharmaceutical Discovery
7.5.1 Biopharmaceutical and Pharmaceutical Discovery Market, 2018 - 2035 (USD Million)
7.6 Biomedical Research
7.6.1 Biomedical Research Market, 2018 - 2035 (USD Million)
Chapter 8 Global Adeno - Associated Virus Contract Development & Manufacturing Organizations Market: End Use Segment Analysis
8.1 Definitions & Scope
8.2 Adeno - Associated Virus Contract Development & Manufacturing Organizations: Market Share Analysis, 2022 & 2035
8.3 Pharmaceutical and Biopharmaceutical Companies
8.3.1 Pharmaceutical and Biopharmaceutical Companies Market, 2018 - 2035 (USD Million)
8.4 Academic & Research Institutes
8.4.1 Academic Research Institutes Market, 2018 - 2035 (USD Million)
Chapter 9 Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market: Regional Estimates and Trend Analysis
9.1.1 North America
9.1.2 SWOT Analysis:
9.1.2.1 North America Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.3 U.S.
9.1.3.1 Key Country Dynamics
9.1.3.2 Target Disease Prevalence
9.1.3.1 Competetive Scenario
9.1.3.2 Regulatory Framework
9.1.3.3 U.S. Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.4 Canada
9.1.4.1 Key Country Dynamics
9.1.4.2 Competitive Scenario
9.1.4.3 Regulatory Framework
9.1.4.4 Canada Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.5 Europe
9.1.6 SWOT Analysis:
9.1.6.1 Europe Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.7 U.K.
9.1.7.1 Key Country Dynamics
9.1.7.2 Competitive Scenario
9.1.7.3 Regulatory Framework
9.1.7.4 U.K. Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.8 Germany
9.1.8.1 Key Country Dynamics
9.1.8.2 Competitive Scenario
9.1.8.3 Regulatory Framework
9.1.8.4 Germany Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.9 France
9.1.9.1 Key Country Dynamics
9.1.9.2 Competitive Scenario
9.1.9.3 Regulatory Framework
9.1.9.4 France Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.10 Italy
9.1.10.1 Key Country Dynamics
9.1.10.2 Competitive Scenario
9.1.10.3 Regulatory Framework
9.1.10.4 Italy Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.11 Spain
9.1.11.1 Key Country Dynamics
9.1.11.2 Competitive Scenario
9.1.11.3 Regulatory Framework
9.1.11.4 Spain Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.12 Denmark
9.1.12.1 Key country dynamics
9.1.12.2 Competitive scenario
9.1.12.3 Regulatory framework
9.1.12.4 Denmark Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.13 Norway
9.1.13.1 Key country dynamics
9.1.13.2 Competitive scenario
9.1.13.3 Regulatory framework
9.1.13.4 Norway generic Contract Manufacturing Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.14 Sweden
9.1.14.1 Key country dynamics
9.1.14.2 Competitive scenario
9.1.14.3 Regulatory framework
9.1.14.4 Sweden Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.15 Belgium
9.1.15.1 Key country dynamics
9.1.15.2 Competitive scenario
9.1.15.3 Regulatory framework
9.1.15.4 Belgium Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.16 Switzerland
9.1.16.1 Key country dynamics
9.1.16.2 Competitive scenario
9.1.16.3 Regulatory framework
9.1.16.4 Switzerland Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.17 Netherland
9.1.14.1 Key country dynamics
9.1.14.2 Competitive scenario
9.1.14.3 Regulatory framework
9.1.14.4 Netherland Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.18 FINLAND
9.1.18.1 Key country dynamics
9.1.18.2 Competitive scenario
9.1.18.3 Regulatory framework
9.1.18.4 FINLAND Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.19 Asia Pacific
9.1.20 SWOT Analysis:
9.1.21 Asia Pacific antibody drug conjugates contract manufacturing organization Market, 2019 - 2035 (USD Million)
9.1.22 Japan
9.1.22.1 Key country dynamics
9.1.22.2 Competitive scenario
9.1.22.3 Regulatory framework
9.1.22.4 Japan generic Contract Manufacturing Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.23 China
9.1.23.1 Key country dynamics
9.1.23.2 Competitive scenario
9.1.23.3 Regulatory framework
9.1.23.4 China generic Contract Manufacturing Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.24 India
9.1.24.1 Key country dynamics
9.1.24.2 Competitive scenario
9.1.24.3 Regulatory framework
9.1.24.4 India generic Contract Manufacturing Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.25 South Korea
9.1.25.1 Key country dynamics
9.1.25.2 Competitive scenario
9.1.25.3 Regulatory framework
9.1.25.4 South Korea vessel sealing devices Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.26 Australia
9.1.26.1 Key country dynamics
9.1.26.2 Competitive scenario
9.1.26.3 Regulatory framework
9.1.26.4 Australia generic Contract Manufacturing Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.27 Singapore
9.1.27.1 Key country dynamics
9.1.27.2 Competitive scenario
9.1.27.3 Regulatory framework
9.1.27.4 Singapore Adeno - Associated Virus (AAV) contract development and manufacturing organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.28 Latin America
9.1.29 SWOT Analysis:
9.1.30 Latin America Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market, 2019 - 2035 (USD Million)
9.1.31 Brazil
9.1.31.1 Key country dynamics
9.1.31.2 Competitive scenario
9.1.31.3 Regulatory framework
9.1.31.4 Brazil Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.32 Mexico
9.1.32.1 Key country dynamics
9.1.32.2 Competitive scenario
9.1.32.3 Regulatory framework
9.1.32.4 Mexico Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.33 Argentina
9.1.33.1 Key country dynamics
9.1.33.2 Competitive scenario
9.1.33.3 Regulatory framework
9.1.33.4 Argentina Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.34 MEA
9.1.35 SWOT Analysis:
9.1.36 MEA Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market, 2019 - 2035 (USD Million)
9.1.37 South Africa
9.1.37.1 Key country dynamics
9.1.37.2 Competitive scenario
9.1.37.3 Regulatory framework
9.1.37.4 South Africa Adeno - Associated Virus (AAV) Contract Development and Manufacturing Organizations Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.38 SAUDI ARABIA
9.1.38.1 Key country dynamics
9.1.38.2 Competitive scenario
9.1.38.3 Regulatory framework
9.1.38.4 Saudi Arabia Generic Drug Contract Manufacturing Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.39 UAE
9.1.39.1 Key country dynamics
9.1.39.2 Competitive scenario
9.1.39.3 Regulatory framework
9.1.39.4 UAE Generic Drug Contract Manufacturing Market estimates and forecasts, 2019 - 2035 (USD Million)
9.1.40 KUWAIT
9.1.40.1 Key country dynamics
9.1.40.2 Competitive scenario
9.1.40.3 Regulatory framework
9.1.40.4 Kuwait Adeno - Associated Virus Contract Manufacturing Market Estimates and forecasts, 2019 - 2035 (USD Million)
Chapter 10 Competitive Landscape
10.1 AAV Service Heatmap Analysis
10.2 Recent development & strategic initiative analysis
10.3 Company Profile
10.4 Thermo Fischer Scientific, Inc.
10.1.1 Company Overview
10.1.2 Service Benchmarking
10.1.3 Financial Performance
10.1.4 Strategic Initiatives
10.5 Creative Biogene
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Service Benchmarking
10.5.4 Strategic Initiatives
10.6 Catalent Inc.
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.2 Service Benchmarking
10.6.3 Strategic Initiatives
10.7 Charles River Laboratories International, Inc.
10.7.1 Company Overview
10.7.2 Financial Performance
10.7.3 Service Benchmarking
10.7.4 Strategic Initiatives
10.8 Danaher (Aldevron)
10.8.1 Company Overview
10.8.2 Financial Performance
10.8.3 Service Benchmarking
10.8.4 Strategic Initiatives
10.9 Genezen
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Service Benchmarking
10.9.4 Strategic Initiatives
10.10 ViroCell Biologics
10.10.1 Company Overview
10.10.2 Financial Performance
10.10.3 Service Benchmarking
10.10.4 Strategic Initiatives
10.11 Merck KGaA
10.11.1 Company Overview
10.11.2 Financial Performance
10.11.3 Service Benchmarking
10.11.4 Strategic Initiatives
10.12 VIRALGEN
10.12.1 Company Overview
10.12.2 Financial Performance
10.12.3 Service Benchmarking
10.12.4 Strategic Initiatives
10.13 Biovian Oy
10.13.1 Company Overview
10.13.2 Financial Performance
10.13.3 Service Benchmarking
10.13.4 Strategic Initiatives
10.14 Esco Lifesciences (Esco Aster Pte. Ltd. )
10.14.1 Company Overview
10.14.2 Financial Performance
10.14.3 Service Benchmarking
10.14.4 Strategic Initiatives
10.15 GenScript ProBio
10.15.1 Company Overview
10.15.2 Financial Performance
10.15.3 Service Benchmarking
10.15.4 Strategic Initiatives
10.16 Porton Advanced Solution Ltd
10.16.1 Company Overview
10.16.2 Financial Performance
10.16.3 Service Benchmarking
10.16.4 Strategic Initiatives
10.17 Ask Bio
10.17.1 Company Overview
10.17.2 Financial Performance
10.17.3 Service Benchmarking
10.17.4 Strategic Initiatives
10.18 Showa Denko
10.18.1 Company Overview
10.18.2 Financial Performance
10.18.3 Service Benchmarking
10.18.4 Strategic Initiatives
10.19 Takara Bio, Inc.
10.19.1 Company Overview
10.19.2 Financial Performance
10.19.3 Service Benchmarking
10.19.4 Strategic Initiatives
10.20 ABL Manufacturing
10.20.1 Company Overview
10.20.2 Financial Performance
10.20.3 Service Benchmarking
10.20.4 Strategic Initiatives
10.21 Oxford Biomedica
10.21.1 Company Overview
10.21.2 Financial Performance
10.21.3 Service Benchmarking
10.21.4 Strategic Initiatives
10.22 Belief Biomed, Inc.
10.22.1 Company Overview
10.22.2 Financial Performance
10.22.3 Service Benchmarking
10.22.4 Strategic Initiatives
10.23 Beijing Anlong Biomedicine Co., Ltd
10.23.1 Company Overview
10.23.2 Financial Performance
10.23.3 Service Benchmarking
10.23.4 Strategic Initiatives
10.24 Forecyte Bio Limited
10.24.1 Company Overview
10.24.2 Financial Performance
10.24.3 Service Benchmarking
10.24.4 Strategic Initiatives
10.25 Gene Pharma, Inc.
10.25.1 Company Overview
10.25.2 Financial Performance
10.25.3 Service Benchmarking
10.25.4 Strategic Initiatives
10.26 Skyline Therapeutics
10.26.1 Company Overview
10.26.2 Financial Performance
10.26.3 Service Benchmarking
10.26.4 Strategic Initiatives
10.27 TFBS Bioscience, Inc.
10.27.1 Company Overview
10.27.2 Financial Performance
10.27.3 Service Benchmarking
10.27.4 Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Difference between adherent and suspension cells
Table 4 Therapies using AAV vector type (2017 - 2022)
Table 5 Gene Therapies
Table 6 Types of viral vectors
Table 7 Examples of AAV vector-based vaccines
Table 8 AAVs clinical trials sites
Table 9 Industry-funded clinical trial sites
Table 10 Academic & research institutes funded clinical trials sites
Table 11 North America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Region, 2018 - 2035 (USD Million)
Table 12 North America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 13 North America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 14 North America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 15 North America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 16 North America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 17 North America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 18 Oversight and regulatory bodies responsible for AAV gene therapy clinical trials.
Table 19 U.S. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 20 U.S. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 21 U.S. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 22 U.S. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 23 U.S. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 24 U.S. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 25 Canada Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 26 Canada Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 27 Canada Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 28 Canada Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 29 Canada Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 30 Canada Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 31 Europe Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Region, 2018 - 2035 (USD Million)
Table 32 Europe Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 33 Europe Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 34 Europe Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 35 Europe Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 36 Europe Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 37 Europe Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 38 U.K. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 39 U.K. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 40 U.K. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 41 U.K. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 42 U.K. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 43 U.K. Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 44 Laws and guidelines to consider for the manufacture of and the treatment of patients with gene therapy drugs in Germany.
Table 45 Germany Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 46 Germany Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 47 Germany Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 48 Germany Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 49 Germany Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 50 Germany Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 51 France Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 52 France Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 53 France Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 54 France Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 55 France Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 56 France Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 57 Italy Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 58 Italy Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 59 Italy Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 60 Italy Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 61 Italy Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 62 Italy Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 63 Spain Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 64 Spain Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 65 Spain Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 66 Spain Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 67 Spain Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 68 Spain Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 69 Denmark Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 70 Denmark Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 71 Denmark Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 72 Denmark Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 73 Denmark Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 74 Denmark Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 75 Norway Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 76 Norway Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 77 Norway Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 78 Norway Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 79 Norway Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 80 Norway Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 82 Sweden Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 83 Sweden Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 84 Sweden Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 85 Sweden Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 86 Sweden Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 82 Belgium Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 83 Belgium Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 84 Belgium Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 85 Belgium Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 86 Belgium Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 87 Belgium Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 93 Asia Pacific Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 94 Asia Pacific Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 95 Japan Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 96 Japan Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 97 Japan Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 98 Japan Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 99 Japan Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 100 Japan Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 101 China Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 102 China Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 103 China Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 104 China Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 105 China Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 106 China Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 107 India Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 108 India Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 109 India Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 110 India Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 111 India Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 112 India Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 113 South Korea Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 114 South Korea Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 115 South Korea Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 116 South Korea Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 117 South Korea Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 118 South Korea Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 119 Australia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 120 Australia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 121 Australia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 122 Australia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 123 Australia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 124 Australia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 125 Singapore Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 126 Singapore Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 127 Singapore Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 128 Singapore Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 129 Singapore Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 130 Malaysia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 131 Malaysia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 132 Malaysia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 133 Malaysia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 134 Malaysia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 135 Thailand Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 136 Thailand Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 137 Thailand Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 138 Thailand Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 139 Thailand Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 140 Thailand Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 141 Latin America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 142 Latin America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 143 Latin America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 144 Latin America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 145 Latin America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 146 Latin America Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 147 Mexico Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by upstream Processing, 2018 - 2035 (USD Million)
Table 148 Mexico Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 149 Mexico Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 150 Mexico Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 151 Mexico Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 152 Argentina Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 153 Argentina Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 154 Argentina Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 155 Argentina Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 156 Argentina Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 157 Brazil Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 158 Brazil Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 159 Brazil Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 160 Brazil Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 161 Brazil Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 162 Brazil Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 163 Middle East & Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 164 Middle East & Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 165 Middle East & Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 166 Middle East & Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 166 Middle East & Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 167 Middle East & Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 168 South Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Work Flow, 2018 - 2035 (USD Million)
Table 169 South Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 170 South Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 171 South Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 172 South Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 173 South Africa Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 174 Saudi Arabia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 175 Saudi Arabia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 176 Saudi Arabia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 177 Saudi Arabia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 178 Saudi Arabia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 179 Saudi Arabia Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 180 UAE Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 181 UAE Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 182 UAE Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 183 UAE Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 184 UAE Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 185 UAE Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
Table 186 Kuwait Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Workflow, 2018 - 2035 (USD Million)
Table 187 Kuwait Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Upstream Processing, 2018 - 2035 (USD Million)
Table 188 Kuwait Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Downstream Processing, 2018 - 2035 (USD Million)
Table 189 Kuwait Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Culture type, 2018 - 2035 (USD Million)
Table 190 Kuwait Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by Application, 2018 - 2035 (USD Million)
Table 191 Kuwait Adeno - Associated Virus Contract Development and Manufacturing Organizations Market, by End-user, 2018 - 2035 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market research approaches
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Primary research pattern
Fig. 8 Primary interviews in North America
Fig. 9 Primary interviews in Europe
Fig. 10 Primary interviews in Asia Pacific
Fig. 11 Primary interviews in Latin America
Fig. 12 Primary interviews in MEA
Fig. 13 Market Snapshot
Fig. 14 Segment Snapshot
Fig. 15 Segment Snapshot
Fig. 16 Competitive Landscape Snapshot
Fig. 17 Global Adeno - associated virus contract development & manufacturing organizations market workflow outlook: Segment dashboard
Fig. 18 Adeno - associated virus contract development & manufacturing organizations market: workflow movement analysis
Fig. 19 Upstream and downstream processes of the AAV workflow.
Fig. 20 Upstream processing market, 2018 - 3035 (USD Million)
Fig. 21 Vector amplification & expansion market, 2018 - 3035 (USD Million)
Fig. 22 Vector recovery & harvesting market, 2018 - 3035 (USD Million)
Fig. 23 Downstream processing market, 2018 - 3035 (USD Million)
Fig. 24 AAV purification process
Fig. 25 Purification market, 2018 - 3035 (USD Million)
Fig. 26 Fill Finish market, 2018 - 3035 (USD Million)
Fig. 27 Adeno - Associated Virus Contract Manufacturing Market Culture Type outlook: Segment dashboard
Fig. 28 Adeno - Associated Virus Contract manufacturing market: culture type movement analysis
Fig. 29 Adherent culture market, 2018 - 2035 (USD Million)
Fig. 30 Suspension culture market, 2018 - 2035 (USD Million)
Fig. 31 Adeno - associated virus contract development & manufacturing organizations market application outlook: Segment dashboard
Fig. 32 Adeno - associated virus contract development & manufacturing market: application type movement analysis
Fig. 33 Cell & gene therapy development market, 2018 - 2035 (USD Million)
Fig. 34 Vaccine development market, 2018 - 2035 (USD Million)
Fig. 35 Pharmaceutical & biotechnology companies market, 2018 - 2035 (USD Million)
Fig. 36 Biomedical research market, 2018 - 2035 (USD Million)
Fig. 37 Adeno - associated virus contract development & manufacturing organizations market end-use outlook: Segment dashboard
Fig. 38 Adeno - associated virus contract development & manufacturing market: end-use movement analysis
Fig. 39 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2035 (USD Million)
Fig. 40 Academic Research Institutes market, 2018 - 2035 (USD Million)
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 Regional marketplace: Key takeaways
Fig. 43 North America: SWOT analysis
Fig. 44 North America Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Target disease prevalence (patient volume) ('000), 2016 - 2028
Fig. 47 Sequence of regulatory approvals for an Adeno - Associated Virus (AAV) gene therapy product development plan.
Fig. 48 U.S. Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Canada Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 51 Europe: SWOT analysis
Fig. 52 Europe Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 U.K. Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Germany Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 France Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Italy Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Spain Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Denmark Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Norway generic contract manufacturing market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Sweden Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 69 Asia Pacific: SWOT analysis
Fig. 70 Asia Pacific market, 2018 - 2035 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 GMOs/LMOs regulations in Japan
Fig. 73 Japan generic contract manufacturing market, 2018 - 2035 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 China regulatory framework
Fig. 76 China Adeno - Associated Virus (AAV) contract development and manufacturing organizations market, 2018 - 2035 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 India generic contract manufacturing market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 South Korea vessel sealing devices market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Australia regulatory framework
Fig. 83 Australia Adeno - Associated Virus (AAV) contract development and manufacturing organizations market, 2018 - 2035 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Singapore registration process for a Class 2 CTGTP
Fig. 86 Thailand Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 87 Latin America: SWOT analysis
Fig. 88 Latin Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Brazil Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Mexico Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Argentina Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 95 MEA: SWOT analysis
Fig. 96 MEA Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 South Africa Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 Saudi Arabia estimated period to obtain a pharmaceutical product manufacturer license
Fig. 101 Saudi Arabia Adeno - Associated Virus (AAV) contract development and manufacturing organizations market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 UAE Adeno - Associated Virus Contract Manufacturing Market estimates and forecasts, 2018 - 2035 (USD Million)
Fig. 104 Key country dynamics
Fig. 105 Kuwait Adeno - Associated Virus Contract Manufacturing Market estimates and forecasts, 2018 - 2035 (USD Million)
Companies Mentioned
- Thermo Fischer Scientific, Inc.
- Creative Biogene
- Catalent Inc.
- Charles River Laboratories International, Inc.
- Danaher (Aldevron)
- Genezen
- ViroCell Biologics
- Merck KGaA
- VIRALGEN
- Biovian Oy
- Esco Lifesciences (Esco Aster Pte. Ltd. )
- GenScript ProBio
- Porton Advanced Solution Ltd
- Ask Bio
- Showa Denko
- Takara Bio, Inc.
- ABL Manufacturing
- Oxford Biomedica
- Belief Biomed, Inc.
- Beijing Anlong Biomedicine Co., Ltd
- Forecyte Bio Limited
- Gene Pharma, Inc.
- Skyline Therapeutics
- TFBS Bioscience, Inc.
Methodology
LOADING...
